7 completed, 4 unknown, 3 not yet recruiting, 3 recruiting. 23 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 23 | Completed 7, Unknown 4, Not yet recruiting 3, Recruiting 3, Active not recruiting 2, Withdrawn 2, Enrolling by invitation 1, Terminated 1 |
Follow Intracranial Arteriosclerosis: new trials by email Literature Review of Intracranial Arteriosclerosis trials Research Report on Intracranial Arteriosclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling Intervention 1, Intervention 3, Intervention 2 - Atherosclerosis Cerebral, Carotid Plaque | Phase 4 | Not yet recruiting | Keqiang Zhao | 120 | 2027-01-01 | 2026-09-15 |
| Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter Trial Rosuvastatin, Ezetimibe, Recaticimab - Intracranial Arteriosclerosis, Cognitive Impairment | Phase 4 | Not yet recruiting | Peking Union Medical College Hospital | 440 | 2026-09-17 | 2026-09-15 |
| PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke Recaticimab plus standard therapy, Recaticimab's placebo in combination with standard therapy - Acute Ischemic Stroke AIS, Intracranial Atherosclerosis ICAS | Phase 4 | Not yet recruiting | Peking Union Medical College Hospital | 1212 | 2026-09-01 | 2026-07-15 |
| BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis Apixaban, Clopidogrel - Stroke, Ischemic | Phase 4 | Recruiting | Yonsei University | 586 | 2026-07-14 | 2026-11-18 |
| Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders Mexidol sequential therapy - Metabolic Abnormalities, Obesity & Overweight | Phase 4 | Active not recruiting | Research Center of Neurology, Russia | 30 | 2026-04-01 | 2026-11-06 |
| PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis Recaticimab and Statin, Statin - Intracranial Atherosclerosis, Intracranial Artery Stenosis | Phase 4 | Recruiting | Peking Union Medical College Hospital | 300 | 2025-11-07 | 2026-06-12 |
| Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis clopidogrel for 90 days combined with aspirin for 90 days, clopidogrel for 30 days combined with aspirin for 90 days - Ischemic Stroke, Intracranial Arteriosclerosis | Phase 4 | Unknown | Sichuan Provincial People's Hospital | 1100 | 2024-07-01 | 2024-06-18 |
| High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study Evolocumab 140 MG/ML, Intensive statin treatment - Cerebral Atherosclerosis | Phase 4 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 200 | 2022-11-09 | 2023-12-11 |
| Reducing Intracranial atheroSclErosis With Repatha Repatha - Ischemic Stroke | Phase 4 | Terminated | University of California, Los Angeles | 10 | 2021-04-23 | 2023-03-15 |
| Predicting Stroke Risk in ICAD With Novel MRI Feraheme - Intracranial Atherosclerosis | Phase 4 | Withdrawn | Northwestern University | 2020-09-01 | 2026-08-06 | |
| Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy Atorvastatin 40 Mg Oral Tablet, Placebo - Dementia, Mixed, Dementia, Vascular | Phase 4 | Active not recruiting | Monash University | 341 | 2019-09-19 | 2025-05-22 |
| The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques Atorvastatin Calcium, Probucol, PCSK9 inhibitor - Stroke, Ischemic, Atherosclerosis, Cerebral | Phase 4 | Recruiting | General Hospital of Shenyang Military Region | 100 | 2018-12-01 | 2026-04-27 |
| Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis Divaza, Placebo - Cerebral Atherosclerosis | Phase 4 | Completed | Materia Medica Holding | 124 | 2018-04-12 | 2021-08-26 |
| Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis Urinary Kallikrein - Intracranial Arteriosclerosis, Collateral Circulation | Phase 4 | Withdrawn | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2016-01-01 | 2020-03-30 | |
| Efficacy of Pain Treatment on Depression in Patients With Dementia Paracetamol, Buprenorphine, Paracetamol placebo - Depression, Pain | Phase 4 | Completed | University of Bergen | 163 | 2014-08-01 | 2017-04-04 |
| Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis High-dose statin: Atorvastatin 40mg or Rosuvastatin 20mg - Stroke, Intracranial Atherosclerosis | Phase 4 | Unknown | Samsung Medical Center | 80 | 2012-02-01 | 2017-04-26 |
| Imaging of Brain Amyloid Plaques in the Aging Population Pittsburgh Compound B (C-11 PiB), F-18 FDG, Tau (18-F-AV-1451) - Alzheimer's Disease, Dementia With Lewy Bodies | Phase 4 | Enrolling by invitation | Mayo Clinic | 8000 | 2008-04-01 | 2026-06-23 |
| Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions Cilostazol, Aspirin - Vascular Dementia, Stroke | Phase 4 | Completed | Peking University First Hospital | 200 | 2008-03-01 | 2015-05-06 |
| Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT) hydrocodone/APAP w placebo PRN, hydrocodone/APAP, placebo with hydrocodone/APAP PRN - Alzheimer Disease, Dementia | Phase 4 | Completed | VA Office of Research and Development | 11 | 2007-10-01 | 2015-11-20 |
| A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia Cerebrolysin, 0.9% Saline Solution - Vascular Dementia | Phase 4 | Completed | Ever Neuro Pharma GmbH | 242 | 2006-10-01 | 2024-02-21 |
Showing 20 of 23. Sign in to see all of them.
Dementia, Vascular (7) · Stroke (5) · Ischemic Stroke (4) · Alzheimer Disease (3) · Dementia (3) · Atherosclerosis (2) · Atrial Fibrillation (2) · Cerebrovascular Disorders (2) · Cognitive Dysfunction (2) · Coronary Disease (2) · Lewy Body Disease (2) · Pain (2) · Plaque, Atherosclerotic (2) · Agnosia (1)
Arterial Occlusive Diseases (23) · Brain Diseases (23) · Central Nervous System Diseases (23) · Intracranial Arterial Diseases (23) · Nervous System Diseases (23) · Vascular Diseases (23) · Arteriosclerosis (22) · Cardiovascular Diseases (22) · Cerebrovascular Disorders (21) · Pathological Conditions, Signs and Symptoms (9) · Mental Disorders (8) · Neurocognitive Disorders (8) · Leukoencephalopathies (7) · Stroke (5)
Atorvastatin (4) · Aspirin (3) · evolocumab (3) · Clopidogrel (2) · Rosuvastatin Calcium (2) · 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1) · Acetaminophen (1) · Adrenergic beta-Antagonists (1) · Angiotensin-Converting Enzyme Inhibitors (1) · Atenolol (1) · Buprenorphine (1) · Cilostazol (1) · Donepezil (1) · Ezetimibe (1) · Ferrosoferric Oxide (1)
Peking Union Medical College Hospital (3) · Eisai Inc. (1) · Ever Neuro Pharma GmbH (1) · Far Eastern Memorial Hospital (1) · General Hospital of Shenyang Military Region (1) · Johns Hopkins University (1) · Keqiang Zhao (1) · Materia Medica Holding (1) · Mayo Clinic (1) · Monash University (1) · Northwestern University (1) · Peking University First Hospital (1) · Research Center of Neurology, Russia (1) · Samsung Medical Center (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1)
China (8) · United States (5) · Russia (3) · South Korea (2) · Australia (1) · Norway (1) · Philippines (1) · Taiwan (1)
A H Li, MD (1) · Andrea Snow, PhD MS BS (1) · Ane Erdal, PhD candidate (1) · Bo Hu, Doctor (1) · Candong Hong, Doctor (1) · Elisabeth Flo, PhD (1) · Huang Yining, MD PhD (1) · Huisheng Chen, Doctor (1) · Jacqueline Dominguez (1) · Jerilyn Allen (1) · Jie Yang, doctor (1) · Jiehong Wu, Doctor (1) · Lei Zhang, Doctor (1) · Min Lou, Ph.D,M.D. (1)
PMID 28304224, PMID 17548554, PMID 17548555, PMID 20656516, PMID 21899409, PMID 21953407, PMID 24489130, PMID 27846344, PMID 29487556, PMID 29725986, PMID 30066942, PMID 31011477, PMID 31371644, PMID 31707788, PMID 31886149, PMID 32561535, PMID 32817184, PMID 33189083, PMID 34353533, PMID 35048716, PMID 35143758, PMID 35833913, PMID 35943472, PMID 37009731, PMID 37056360, PMID 37738517, PMID 37920607, PMID 38048667, PMID 38212060, PMID 38648030, PMID 38817546, PMID 39087353, PMID 39387764, PMID 39505412, PMID 39548030, PMID 39755915, PMID 39818872, PMID 40616232, PMID 40820974, PMID 41107765, PMID 41389830, PMID 41500725, PMID 41582814, PMID 42262770
R01AG011378 (1), R01HL082638 (1), U01AG006786 (1)